Cancer Rop Co. Ltd. Asset Resilience Ratio

Latest as of March 2026: 1.37%

Cancer Rop Co. Ltd. asset resilience ratio. Cancer Rop Co. Ltd. (180400) has an Asset Resilience Ratio of 1.37% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Cancer Rop Co. Ltd. defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Liquid Assets

₩1.58 Billion

≈ $1.07 Million USD Cash + Short-term Investments

Total Assets

₩115.39 Billion

≈ $78.20 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio of Cancer Rop Co. Ltd. (2014–2025)

Asset resilience ratio of Cancer Rop Co. Ltd. from 2014 to 2025. This chart shows how Cancer Rop Co. Ltd.'s Asset Resilience Ratio has changed over time. Read Cancer Rop Co. Ltd. balance sheet liabilities for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Cancer Rop Co. Ltd.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Cancer Rop Co. Ltd. (180400) total assets.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩0.00	0%
Short-term Investments	₩1.58 Billion	1.37%
Total Liquid Assets	₩1.58 Billion	1.37%

Asset Resilience Insights

Limited Liquidity: Cancer Rop Co. Ltd. maintains only 1.37% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Cancer Rop Co. Ltd. Industry Peers by Asset Resilience Ratio

Compare Cancer Rop Co. Ltd.'s asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Voxel S.A. WAR:VOX	Diagnostics & Research	0.32%
Leveljump Healthcare Corp V:JUMP	Diagnostics & Research	32.45%
Prodia Widyahusada Tbk PT JK:PRDA	Diagnostics & Research	7.82%
Sonic Healthcare Ltd AU:SHL	Diagnostics & Research	0.13%
Integral Diagnostics Ltd AU:IDX	Diagnostics & Research	0.03%
Australian Clinical Labs Ltd AU:ACL	Diagnostics & Research	4.11%
Healius Ltd AU:HLS	Diagnostics & Research	0.06%
Monash Ivf Group Ltd AU:MVF	Diagnostics & Research	1.60%

Cancer Rop Co. Ltd. Asset Resilience Ratio by Year (2014–2025)

Cancer Rop Co. Ltd. asset resilience ratio by year from 2014 to 2025. The table below shows the annual Asset Resilience Ratio data for Cancer Rop Co. Ltd..

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	1.02%	₩1.58 Billion ≈ $1.07 Million	₩154.87 Billion ≈ $104.96 Million	-1.19pp
2024-12-31	2.21%	₩1.60 Billion ≈ $1.08 Million	₩72.36 Billion ≈ $49.04 Million	-2.84pp
2023-12-31	5.05%	₩5.04 Billion ≈ $3.42 Million	₩99.94 Billion ≈ $67.73 Million	+3.23pp
2022-12-31	1.81%	₩1.56 Billion ≈ $1.06 Million	₩85.95 Billion ≈ $58.25 Million	+0.40pp
2018-12-31	1.41%	₩950.92 Million ≈ $644.42K	₩67.54 Billion ≈ $45.77 Million	-32.27pp
2016-12-31	33.67%	₩10.00 Billion ≈ $6.78 Million	₩29.70 Billion ≈ $20.13 Million	-11.88pp
2015-12-31	45.55%	₩10.10 Billion ≈ $6.84 Million	₩22.17 Billion ≈ $15.03 Million	+44.25pp
2014-12-31	1.30%	₩100.00 Million ≈ $67.77K	₩7.70 Billion ≈ $5.22 Million	--

pp = percentage points

About Cancer Rop Co. Ltd.

KQ:180400 Korea Diagnostics & Research

Market Cap

$121.40 Million

₩179.14 Billion KRW

Market Cap Rank

#18275 Global

#799 in Korea

Share Price

₩1820.00

Change (1 day)

-3.60%

52-Week Range

₩1820.00 - ₩2760.00

All Time High

₩2760.00